Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Ebina, Hirotaka ^a   Misawa, Naoko ^a   Kanemura, Yuka ^a   Koyanagi, Yoshio ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 9; CRISPR ASSOCIATED PROTEIN;

CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; GENE SILENCING; GENETICS; GROWTH, DEVELOPMENT AND AGING; HEK293 CELL LINE; HELA CELL LINE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERMINAL REPEAT; VIRUS LATENCY; ARTICLE; CELL STRAIN HEK293; HELA CELL;

CASPASE 9; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS; CRISPR-ASSOCIATED PROTEINS; GENE SILENCING; HEK293 CELLS; HELA CELLS; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; VIRUS LATENCY;

EID: 84883305437     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep02510     Document Type: Article

References (28)

1. Craigie, R. & Bushman, F. D. HIV DNA Integration. Cold Spring Harbor perspectives in medicine 2, a006890 (2012).
2. Karn, J. & Stoltzfus, C. M. Transcriptional and posttranscriptional regulation of HIV-1 gene expression. Cold Spring Harbor perspectives in medicine 2, a006916 (2012).
3. Siliciano, R. F. & Greene, W. C. HIV latency. Cold Spring Harbor perspectives in medicine 1, a007096 (2011).
4. Jordan, A., Defechereux, P. & Verdin, E. The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation. EMBO J. 20, 1726-1738 (2001). (Pubitemid 32299409)
5. Eisele, E. & Siliciano, R. F. Redefining the viral reservoirs that prevent HIV-1 eradication. Immunity 37, 377-388 (2012).
6. Urnov, F. D. et al. Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature 435, 646-651 (2005). (Pubitemid 40825505)
7. Mahfouz, M. M. et al. De novo-engineered transcription activator-like effector (TALE) hybrid nuclease with novel DNA binding specificity creates doublestrand breaks. Proc. Natl. Acad. Sci. U. S. A. 108, 2623-2628 (2011).
8. Liu, J. et al. Efficient and specific modifications of the Drosophila genome by means of an easy TALEN strategy. Journal of genetics and genomics. 39, 209-215 (2012).
9. Huang, P. et al. Heritable gene targeting in zebrafish using customized TALENs. Nat. Biotechnol. 29, 699-700 (2011).
10. Dolgin, E. The knockout rat pack. Nat. Med. 16, 254-257 (2010).
11. Klug,A. The discovery of zinc fingers and their applications in gene regulation and genome manipulation. Annu. Rev. Biochem. 79, 213-231 (2010).
12. Wiedenheft, B., Sternberg, S. H. & Doudna, J. A. RNA-guided genetic silencing systems in bacteria and archaea. Nature 482, 331-338 (2012).
13. Mali, P. et al. RNA-guided human genome engineering via Cas9. Science 339, 823-826 (2013).
14. Cho, S.W., Kim, S., Kim, J. M.&Kim, J. S. Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nat. Biotechnol. 31, 230-232 (2013).
15. Makarova, K. S., Grishin, N. V., Shabalina, S. A., Wolf, Y. I. & Koonin, E. V. A putative RNA-interference-based immune system in prokaryotes: computational analysis of the predicted enzymatic machinery, functional analogies with eukaryotic RNAi, and hypothetical mechanisms of action. Biology direct 1, 7 (2006).
16. Gasiunas, G., Barrangou, R., Horvath, P. & Siksnys, V. Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc. Natl. Acad. Sci. U. S. A. 109, E2579-2586 (2012).
17. Wiedenheft, B. et al. Structures of the RNA-guided surveillance complex from a bacterial immune system. Nature 477, 486-489 (2011).
18. Flory, E. et al. Plasma membrane-targeted Raf kinase activates NF-kappaB and human immunodeficiency virus type 1 replication in T lymphocytes. J. Virol. 72, 2788-2794 (1998). (Pubitemid 28175515)
19. Richter, S., Cao, H. & Rana, T. M. Specific HIV-1 TAR RNA loop sequence and functional groups are required for human cyclin T1-Tat-TAR ternary complex formation. Biochemistry (Mosc). 41, 6391-6397 (2002). (Pubitemid 34526004)
20. Cong, L. et al. Multiplex genome engineering using CRISPR/Cas systems. Science 339, 819-823 (2013).
21. Rodriguez, M. A. et al.Genetic and functional characterization of the LTR of HIV-1 subtypes A and C circulating in India. AIDS Res. Hum. Retroviruses 23, 1428-1433 (2007).
22. Gaj, T.,Gersbach, C.A.&Barbas, C. F. 3rd. ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol. (2013).
23. Holkers, M. et al. Differential integrity of TALE nuclease genes following adenoviral and lentiviral vector gene transfer into human cells. Nucleic Acids Res 41, e63 (2013).
24. Ebina, H. et al. Integrase-independent HIV-1 infection is augmented under conditions of DNA damage and produces a viral reservoir. Virology 427, 44-50 (2012).
25. Jordan, A., Bisgrove, D. & Verdin, E. HIV reproducibly establishes a latent infection after acute infection of T cells in vitro. EMBO J. 22, 1868-1877 (2003). (Pubitemid 36460143)
26. Miyoshi, H., Blomer, U., Takahashi, M., Gage, F. H. & Verma, I. M. Development of a self-inactivating lentivirus vector. J. Virol. 72, 8150-8157 (1998).
27. Godbey, W. T., Zhang, X. & Chang, F. The importance of and a method for including transfection efficiency into real-time PCR data analyses. Biotechnol. Bioeng. 100, 765-772 (2008). (Pubitemid 351916675)
28. Suzuki, Y. et al. Quantitative analysis of human immunodeficiency virus type 1 DNA dynamics by real-time PCR: integration efficiency in stimulated and unstimulated peripheral blood mononuclear cells. Virus Genes 27, 177-188 (2003). (Pubitemid 37255568)